NASDAQ:ALRN
Delisted

Aileron Therapeutics Stock Predictions

etoro logo Buy ALRN
*Your capital is at risk
$2.11
+0 (+0%)
At Close: Apr 09, 2025
Currently predicting for Mon, 8 Jun 2026

ALRN Prediction Chart

ALRN Predictions History

Latest community submissions for ALRN.
Predictor Target Session Target Price Result Direction Accuracy Score
Skagitqg Skagitqg Merchant
Feb 23, 2024 Bullish $4.64 X 0
Feb 21, 2024 $4.55 -3.69% $4.66 V 97.49% 1
Feb 21, 2024 $4.61 -2.31% $4.66 V 98.90% 2
Skagitqg Skagitqg Merchant
Feb 21, 2024 Bullish $4.66 X 0
JS JS Pro
Feb 16, 2021 $2.03 -94.82% $1.96 X 96.43% 0
Vic Chandrasma Vic Chandrasma @VicChandrasma.208179
Feb 16, 2021 Bullish $1.96 X 0
JS JS Pro
Feb 8, 2021 $2.11 -95.05% $2.13 V 99.06% 2
JS JS Pro
Feb 5, 2021 $2.06 -95.30% $2.19 V 94.06% 0
Jan 25, 2021 $2.88 -93.51% $2.22 X 70.27% 1
JS JS Pro
Nov 13, 2020 $1.03 -95.10% $1.05 V 98.10% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ALRN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT AILERON THERAPEUTICS INC
Aileron Therapeutics
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,...
GOLDEN STAR
Ticker Change Signal Date
FISV
0% Nov 30
K
KEEL
0% Nov 30
D
DFTX
0% Nov 30
R
RKLZ
0% Nov 30
R
RKTO
0% Nov 30

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE